نتائج البحث

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg 'Pfizer' Drug Use Investigation (Rheumatoid Arthritis)

• Source: Infliximab BS for Intravenous Drip Infusion 100 mg "Pfizer" General Investigation (Rheumatoid Arthritis)

تفاصيل العنوان

A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

• Source: Infliximab-Pfizer Biosimilar Post-Marketing Database Study

تفاصيل العنوان

Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care.

• Authors : Glintborg B; a The Danish Rheumatologic Biobank, the DANBIO Registry and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics , Rigshospitalet , Glostrup , Denmark.; b Department of Rheumatology, Gentofte and Herlev Hospital , Copenhagen University Hospital , Gentofte , Denmark.

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*blood ; Arthritis/Arthritis/Arthritis/*drug therapy ; Infliximab/Infliximab/Infliximab/*administration & dosage

• Source: Scandinavian journal of rheumatology [Scand J Rheumatol] 2018 Sep; Vol. 47 (5), pp. 418-421. Date of Electronic Publication: 2018 Jan 09.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0321213 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease (SIC2)

• Source: Switch From Intravenous to Subcutaneous Infliximab (REMSIMA®) in Clinical Practice in the Rheumatology Department of Cochin Hospital

تفاصيل العنوان

The Study of Infliximab (CMAB008 and Remicade) in Healthy Subjects to Compare the PK and Safety

• Source: The Study of Infliximab (CMAB008 and Remicade) in Healthy Subjects to Compare the PK and Safety

تفاصيل العنوان

Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis (OPTIWIT)

• Authors : Kei Ikeda, Senior Lecturer

• Source: Multicenter Prospective Trial to Investigate Accuracy of Ultrasound to Predict Relapse After Discontinuation of Infliximab and Efficacy/Safety of Readministration of

تفاصيل العنوان

Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis (AWARE)

• Source: Comparative and Pragmatic Study of Simponi Aria Versus Remicade in Rheumatoid ArthritisCurtis JR, Chakravarty SD, Black S, Kafka S, Xu S, Langholff W, Parenti D,

تفاصيل العنوان

Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan (PASSRRA)

• Authors : Syneos Health

• Source: Post-Authorization Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan

تفاصيل العنوان

National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life (ReFLECT)

• Source: OBSERVATOIRE NATIONAL D'UTILISATION D'INFLECTRA™ EN VIE RÉELLE.

تفاصيل العنوان

A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab

• Source: A PHASE II RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OCRELIZUMAB IN COMBINATION WITH METHOTREXATE, COMPARED TO INFLIXIMAB

تفاصيل العنوان